Brevicon 1/35 · DIN 02189054 · 0.035 mg & 1 mg · tablets, 21-pack
General benefitMarketed · checked November 18, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Brevicon 1/35 · DIN 02189054
Manufacturer: Pfizer Canada Inc.; listing date 1996-10-01
Health Canada: Marketed since 2009-02-03 · brand BREVICON 1/35 TABLETS (21-DAY PACK) · ATC G03AA05 NORETHISTERONE AND ESTROGEN · form Tablet · route Oral · ingredients NORETHINDRONE 1 MG, ETHINYL ESTRADIOL 0.035 MG · company Pfizer canada ulc · schedule Prescription
Brevicon 1/35: Formulary list price $16.45 per unit (the source does not state the unit; exact figure $16.4500). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02189054)
Source record
DIN 02189054: Brevicon 1/35
Raw flags: sec3=Y
Item: 683200053; group id 798; item number 1947; lccId None; manufacturer id PFI
Source form: Tab-21 Pk; strength: 0.035mg & 1mg
Recorded listing: General benefit
Source prices (unrounded): $16.4500; ministry $16.4500
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02189054
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=42921
Shortage status: not checked (no credentials)